10 slide deck about triple negative breast cancer
10 slide deck about triple negative breast cancer
Created using ChatSlide
Triple-negative breast cancer (TNBC) is characterized by its unique receptor profile and presents significant challenges in incidence, survival, and recurrence. Early risk assessment is crucial. Advances in diagnosis and treatment leverage pathology and biomarkers, comparing options like surgery, chemotherapy, and immunotherapy, exemplified by the KEYNOTE-522 trial with pembrolizumab. Ongoing efforts focus on tracking outcomes, addressing disparities in access to care, and personalizing...